Valentini, Vincenzo
 Distribuzione geografica
Continente #
NA - Nord America 16.525
EU - Europa 15.633
AS - Asia 3.141
AF - Africa 160
SA - Sud America 63
OC - Oceania 49
Continente sconosciuto - Info sul continente non disponibili 34
Totale 35.605
Nazione #
US - Stati Uniti d'America 16.343
DE - Germania 5.266
SE - Svezia 3.538
CN - Cina 1.977
IT - Italia 1.746
UA - Ucraina 1.327
IE - Irlanda 1.003
FR - Francia 828
GB - Regno Unito 502
IN - India 473
PL - Polonia 396
FI - Finlandia 392
TR - Turchia 241
BE - Belgio 169
CA - Canada 149
CI - Costa d'Avorio 125
RU - Federazione Russa 93
JP - Giappone 84
CZ - Repubblica Ceca 81
IR - Iran 81
SG - Singapore 58
HK - Hong Kong 56
NL - Olanda 55
AT - Austria 50
AU - Australia 44
CH - Svizzera 41
VN - Vietnam 38
ES - Italia 34
RO - Romania 24
EU - Europa 22
MX - Messico 22
BR - Brasile 20
CL - Cile 18
KR - Corea 18
PE - Perù 18
IL - Israele 15
NO - Norvegia 15
ID - Indonesia 13
GR - Grecia 11
PH - Filippine 11
PT - Portogallo 11
A2 - ???statistics.table.value.countryCode.A2??? 10
MY - Malesia 9
EG - Egitto 8
RS - Serbia 8
SA - Arabia Saudita 8
DK - Danimarca 7
DZ - Algeria 7
PA - Panama 7
PK - Pakistan 7
AE - Emirati Arabi Uniti 6
LK - Sri Lanka 6
MA - Marocco 6
IQ - Iraq 5
MD - Moldavia 5
NZ - Nuova Zelanda 5
BD - Bangladesh 4
BH - Bahrain 4
HU - Ungheria 4
KZ - Kazakistan 4
LU - Lussemburgo 4
MT - Malta 4
TH - Thailandia 4
TW - Taiwan 4
AM - Armenia 3
BG - Bulgaria 3
BZ - Belize 3
CY - Cipro 3
EC - Ecuador 3
HR - Croazia 3
KE - Kenya 3
KW - Kuwait 3
LT - Lituania 3
A1 - Anonimo 2
AL - Albania 2
AR - Argentina 2
LV - Lettonia 2
MK - Macedonia 2
MU - Mauritius 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
BY - Bielorussia 1
CM - Camerun 1
CO - Colombia 1
CU - Cuba 1
ET - Etiopia 1
GE - Georgia 1
JO - Giordania 1
MN - Mongolia 1
MW - Malawi 1
NG - Nigeria 1
NP - Nepal 1
QA - Qatar 1
TN - Tunisia 1
UZ - Uzbekistan 1
VA - Santa Sede (Città del Vaticano) 1
VE - Venezuela 1
ZA - Sudafrica 1
ZW - Zimbabwe 1
Totale 35.605
Città #
Chandler 3.995
Ashburn 1.309
Dublin 998
Jacksonville 815
San Mateo 755
Ann Arbor 633
New York 523
Nanjing 514
Wilmington 512
Milan 400
Woodbridge 376
Warsaw 365
Boston 358
Dearborn 354
Princeton 290
Nürnberg 289
Beijing 284
Fairfield 272
Houston 263
Marseille 261
Bremen 245
Lawrence 243
Cattolica 230
Rome 224
Izmir 218
Redwood City 201
Seattle 180
Nanchang 179
Brussels 166
Zhengzhou 150
Helsinki 126
Abidjan 125
Los Angeles 117
Chicago 111
Munich 104
Boardman 95
Shenyang 91
Leawood 90
Kunming 86
Norwalk 82
Hebei 73
Jiaxing 73
Pune 73
Augusta 70
Cambridge 70
Tianjin 69
Detroit 66
Changsha 65
Mountain View 65
University Park 65
Washington 65
Fremont 64
Toronto 60
Shanghai 58
Hangzhou 57
Falls Church 47
Redmond 46
Vienna 46
Phoenixville 43
North York 42
San Diego 42
Lancaster 41
Andover 39
London 36
Guangzhou 35
Hong Kong 35
Jinan 35
Leesburg 34
Hefei 31
Simi Valley 28
Hanoi 27
Monmouth Junction 27
Kish 26
Auburn Hills 23
Busto Arsizio 23
Ningbo 23
Edinburgh 22
Singapore 22
Brno 21
Lanzhou 21
Tokyo 21
Kraków 20
Amsterdam 19
Ardabil 19
Cuauhtémoc 19
Frankfurt am Main 19
Bologna 18
Indiana 18
Phoenix 18
San Francisco 18
San Jose 18
Dresden 17
Ottawa 16
Lima 15
Las Vegas 14
Paris 14
Berlin 13
Chengdu 13
Sacramento 13
Changchun 12
Totale 18.771
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 789
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 303
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 249
Neoadjuvant Concurrent Radiochemotherapy in Locally Advanced (IIIa-IIIb) Non-Small Cell Lung Cancer: long term results according to downstaging. 237
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study 222
EP-1325 Personalized Medicine in breast cancer: a nomogram from prognostic score to deescalate radiotherapy 216
The role of radiotherapy (RT) in the treatment of Adenoid Cystic Carcinoma of the Breast: case report of RT retreatment and literature review 215
Diffusion-Weighted Magnetic Resonance Imaging in Monitoring Rectal Cancer Response to Neoadjuvant Chemoradiotherapy. 210
Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study. 204
Rectal cancer multidisciplinary treatment: evidences, consensus and perspectives. 194
EP-1181: Prostheses irradiation in breast cancer: clinical and aesthetic outcomes in retrospective series 191
Can Elderly Patients With Newly Diagnosed Glioblastoma be Enrolled in Radiochemotherapy Trials? 186
HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker? 185
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 172
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 164
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 164
Automatic delineation for replanning in nasopharynx radiotherapy: what is the agreement among experts to be considered as benchmark? 162
Medicine is a science of uncertainty and an art of probability (Sir W. Osler) 161
Multidisciplinary approach in the treatment of T1 glottic cancer. The role of patient preference in a homogenous patient population 160
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 160
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 157
Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092) 156
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 156
Diagnosis and treatment of bone metastases in breast cancer: Radiotherapy, local approach and systemic therapy in a guide for clinicians 155
Adjuvant radiotherapy in non small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. 154
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemoterapy and radioation therapy 141
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 141
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 140
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. 138
Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysis. 135
Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. 134
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 132
 ¹⁸F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose. 132
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 131
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 131
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. 130
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 130
Radiosurgery or Fractionated Stereotactic Radiotherapy plus Whole-brain Radioherapy in Brain Oligometastases: A Long-term Analysis 130
Outcomes of clinical t4m0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience. 129
Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemtoherapy and surgery. A prospective evalation of a single institutional experience. 129
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 127
Human papillomavirus (HPV) infection in squamous cell carcinomas arising from the oropharynx: detection of HPV DNA and p16 immunohistochemistry as diagnostic and prognostic indicators--a pilot study 127
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 125
Is two-dimensional field definition sufficient for pelvic node coverage in rectal cancer compared to technical three-dimensional definition? 125
Reducing heart dose during left breast cancer radiotherapy: comparison among 3 radiation techniques 124
Clinical validation of atlas-based auto-segmentation of pelvic volumes and normal tissue in rectal tumors using auto-segmentation computed system 123
Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials 122
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 122
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 122
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 121
Evidence and research perspectives for surgeons in the European Rectal Cancer Consensus Conference (EURECA-CC2). 120
A feasibility study of neo-adjuvant low-dose fractionated radiotherapy with two different concurrent anthracycline-docetaxel schedules in stage IIA/B-IIIA breast cancer 120
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 119
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go 119
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 118
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 118
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 118
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 118
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 118
Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: short-term morbidity and functional outcome. 117
Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy 116
Oncological outcome of hypopharyngeal carcinoma treated with different modalities at two different university hospitals 116
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 115
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 113
The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy 113
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 112
International consensus guidelines on Clinical Target Volume delineation in rectal cancer 112
Multiple abscesses in a patient treated with cetuximab 111
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 110
Oncological outcome in advanced laryngeal cancers treated with different modalities in a single institution. A retrospective analysis on 65 cases. 109
Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma: final report of a pilot study 108
Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach 107
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 106
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 105
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 104
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 104
Comparison of total laryngectomy with surgical (cricohyoidopexy) and nonsurgical organ-preservation modalities in advanced laryngeal squamous cell carcinomas: A multicenter retrospective analysis 104
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 103
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 103
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 103
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 102
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 102
Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy? 102
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 102
HPV and EBV Infections in Neck Metastases from Occult Primary Squamous Cell Carcinoma: Another Virus-Related Neoplastic Disease in the Head and Neck Region 102
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 101
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 100
Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma 99
Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases 99
No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term results of a randomized trial (I-CNR-RT) 99
Lung abnormalities at multimodality imaging after radiation therapy for non-small cell lung cancer 98
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 98
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 97
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 97
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 97
Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO gastrointestinal group experience 97
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 97
Cutaneous squamous cell carcinoma. Italian guidelines by SIDeMaST adapted to and updating EADO/EDF/EORTC guidelines 96
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 96
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 95
Totale 13.898
Categoria #
all - tutte 139.541
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.541


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019635 0 0 0 0 0 0 0 0 0 0 402 233
2019/20204.894 785 216 191 167 430 424 538 242 574 293 673 361
2020/20213.377 204 379 108 375 503 152 339 79 368 213 544 113
2021/20225.239 514 306 103 403 253 169 80 719 231 348 1.126 987
2022/202311.179 1.565 1.531 867 1.742 668 1.306 563 870 1.243 241 412 171
2023/20244.320 227 1.519 224 365 239 851 322 299 79 191 4 0
Totale 36.757